Patterns of recurrence in patients with curative resected rectal cancer according to different chemoradiotherapy strategies: Does preoperative chemoradiotherapy lower the risk of peritoneal recurrence?

peritoneal recurrence post-operative chemoradiotherapy pre-operative chemoradiotherapy rectal neoplasms recurrence pattern

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 18 05 2020
accepted: 10 08 2020
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 26 9 2020
Statut: ppublish

Résumé

The present study aimed to compare the pattern of distant recurrence between patients with non-metastatic rectal cancer treated with pre-operative (OP) and those treated with post-operative (post-OP) chemoradiotherapy (CRT). A total of 631 patients with newly diagnosed non-metastatic rectal cancer who had received pre-OP or post-OP CRT with curative intent surgery between August 2008 and April 2015 were identified. Inverse probability of treatment weighting (IPTW) was performed to account for baseline differences between the two arms. Overall, 449 and 182 patients were treated with pre-OP and post-OP CRT, respectively. Sex, tumor location, clinical tumor stage, CRT regimen and adjuvant chemotherapy regimen were significantly different between the two arms. The median follow-up duration was 55.4 months (range, 53.7-57.1). The 5-year distant recurrence-free survival (RFS) rates and 5-year overall survival (OS) rates were not significantly different between the pre-OP and post-OP CRT arms (RFS, 67.5 vs. 71.6%, P=0.595 and OS, 81.9 vs. 77.0%, P=0.449), and no difference was observed in the distant recurrence patterns. Following IPTW, there was still no difference in distant RFS (pre-OP vs. post-OP CRT; hazard ratio (HR)=0.62; P=0.911), but pre-OP CRT was significantly associated with lower peritoneal recurrence (pre-OP vs. post-OP CRT; HR, 0.13; P=0.032). In addition, there was no significant difference in OS between the two arms (pre-OP vs. post-OP CRT; HR, 0.85; P=0.665). In conclusion, although distant RFS was not significantly different between the two arms, pre-OP CRT was significantly associated with a lower risk of peritoneal recurrence than post-OP CRT in patients non-metastatic rectal cancer.

Identifiants

pubmed: 32973956
doi: 10.3892/ol.2020.12105
pii: OL-0-0-12105
pmc: PMC7509510
doi:

Types de publication

Journal Article

Langues

eng

Pagination

242

Informations de copyright

Copyright © 2020, Spandidos Publications.

Références

Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Am J Epidemiol. 2006 Jun 15;163(12):1149-56
pubmed: 16624967
Int J Colorectal Dis. 2015 Jun;30(6):775-85
pubmed: 25796493
World J Surg Oncol. 2014 Jun 30;12:197
pubmed: 24980147
Radiat Oncol J. 2017 Sep;35(3):198-207
pubmed: 29037017
N Engl J Med. 1991 Mar 14;324(11):709-15
pubmed: 1997835
Colorectal Dis. 2014 May;16(5):359-67
pubmed: 24410859
J Pathol. 2004 Oct;204(2):183-92
pubmed: 15378567
Ann Oncol. 2014 Mar;25(3):651-657
pubmed: 24504447
Nat Rev Clin Oncol. 2017 Jan;14(1):32-44
pubmed: 27550857
Epidemiology. 2000 Sep;11(5):550-60
pubmed: 10955408
Nat Rev Cancer. 2015 Jul;15(7):409-25
pubmed: 26105538
Lancet Oncol. 2011 Jun;12(6):575-82
pubmed: 21596621
J Clin Oncol. 2012 Jun 1;30(16):1926-33
pubmed: 22529255
Br J Surg. 2005 Feb;92(2):225-9
pubmed: 15609382
N Engl J Med. 2004 Oct 21;351(17):1731-40
pubmed: 15496622
Lancet Oncol. 2012 Jun;13(6):579-88
pubmed: 22503032
J Natl Cancer Inst. 2000 Mar 1;92(5):388-96
pubmed: 10699069
Ann Surg. 2012 Jul;256(1):111-6
pubmed: 22664562
Pathol Int. 2016 May;66(5):273-80
pubmed: 27112135
Stat Med. 2015 Dec 10;34(28):3661-79
pubmed: 26238958
Lancet Oncol. 2014 Oct;15(11):1245-53
pubmed: 25201358
Am J Clin Oncol. 2013 Dec;36(6):572-9
pubmed: 22992624
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Biol Sci. 2016 Jul 17;12(8):1022-31
pubmed: 27489505

Auteurs

Hyungwoo Cho (H)

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Jeong Eun Kim (JE)

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Sun Young Kim (SY)

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Kyu-Pyo Kim (KP)

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Tae Won Kim (TW)

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Jin-Hong Park (JH)

Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Jong Hoon Kim (JH)

Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Seok-Byung Lim (SB)

Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Chang Sik Yu (CS)

Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Jin Cheon Kim (JC)

Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Yong Sang Hong (YS)

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Classifications MeSH